Zhejiang Taimei Medical Technology Co., Ltd. (FRA:A2V)

Germany · Delayed Price · Currency is EUR

0.7050

+0.0550 (8.46%)

At close: Jun 26, 2026

89.52% (1Y)

Market Cap	409.61M +91.6%
Revenue (ttm)	62.41M -7.0%
Net Income	-5.22M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.6900
Previous Close	0.6500
Day's Range	0.6850 - 0.7050
52-Week Range	0.3500 - 0.7050
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About FRA:A2V

Zhejiang Taimei Medical Technology Co., Ltd. provides digital solutions for life sciences research, development, and commercialization in Mainland China and internationally. The company offers Wiz.AI, an AI platform for clinical trials; TrialOS pharmaceutical R&D collaboration platform; PharmaOS, a pharmaceutical digital marketing platform; and the enterprise-medical academic interaction platform. It also provides pharmaceutical R&D solutions comprising eCollect, eBalance, eCooperate, eArchives, eImage medical imaging evaluation system, eSMS si... [Read more]

Industry Commercial Physical and Biological Research

Founded 2013

Employees 681

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol A2V

Financial Performance

In 2025, FRA:A2V's revenue was 512.54 million, a decrease of -7.01% compared to the previous year's 551.16 million. Losses were -42.85 million, -80.04% less than in 2024.

Financial numbers in CNY Financial Statements